• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Health News > June 16, 2010

      New Drug to Cut Flab of Diabetics

      Posted AtExpressindia.com

      New Delhi Obese diabetics will soon have a better option to reduce their weight and consequently their blood sugar levels, with a new drug, Victoza (liraglutide), all set to be launched in India this month.

      Already launched in Europe and the US, the drug will hit the stores in India — one of the countries with the highest disease burden and which has over 650 brands of anti-diabetic drugs already available — on June 6. Victoza by Novo Nordisk, according to doctors, will be another option to injectable Byetta, introduced in 2008, and other oral weight-reducing diabetes drugs.

      While Victoza will also be injectable, it is an improvement over the other anti-diabetes drugs used to reduce weight like Januvia and Metformin, say doctors. Their opinion is based on a recent study published in the Lancet, which compared Victoza with Januvia.

      The study suggested that Victoza “produced greater reductions” than Januvia. The study was a 26-week randomised trial, comparing safety and efficacy of two recommended doses of Victoza (1.2 and 1.8 mg) with one daily dose of Januvia (100 mg), all added to Metformin.

      The study was conducted in Europe and North America on 665 people with type II diabetes.

      Says Dr Anoop Misra, Director and Head (Department of Diabetes and Metabolic Diseases), Fortis hospitals: “It will be a good drug for obese diabetics — one step ahead of other weight-reducing Metformin, which reduces 1-2 kgs of weight, and Byetta, which reduces about 3-4 kgs of weight.”

      Dr Misra says Victoza, however, cannot be compared with insulin as Victoza doesn’t produce “very low blood sugar levels”. “Though the drug has been evaluated for three years, in real-life situation we do not have more details. While the experiment on animals has reported thyroid tumours, in humans no such problem is reported but one needs to be cautious. Nausea may also be a side effect in 20 per cent of the people,” he adds.

      In April 2009, a US Food and Drug Administration (FDA) advisory committee expressed its concern that the drug may cause thyroid tumours in mice and rats. In January 2010, however, the FDA approved Victoza for the treatment of type II diabetes in adults.

      The drug has been approved as an auxiliary treatment to diet and exercise to enhance glycaemic control in adults suffering from type II diabetes.

      June 16, 2010


      Share this Article!

    Back to top^